Biogen: LEQEMBI Lecanemab) Approved for the Treatment of Alzheimer's Disease in South Korea
TOKYO and CAMBRIDGE, Mass., May 28, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Food and Drug Safety (MFDS) in South Korea has approved humanized anti-soluble